Anti-CD40 Antibodies Fused to CD40 Ligand Have Superagonist Properties

The authors showed that direct fusion of CD40L to certain agonistic anti-CD40 Abs conferred superagonist properties, reducing the dose required for efficacy, notably greatly increasing total cytokine secretion by human dendritic cells.